ArticleFrontiers in oncology2018

A Phase Ib/II Study of Ganetespib With Doxorubicin in Advanced Solid Tumors Including Relapsed-Refractory Small Cell Lung Cancer.

Deepa S Subramaniam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.